• View the talks
• 36 min
  1. Streptococcus pneumoniae: serotype diversity and epidemiology

  • Dr. Bambos Charalambous
• 38 min
  2. Tuberculosis: new treatments in evolution

  • Prof. Stephen Gillespie
• 55 min
  3. Current drugs for TB treatment

  • Dr. Kasha Singh
• 41 min
  4. Global progress in TB vaccine development

  • Prof. Helen McShane
• 34 min
  5. Management of MDR and XDR TB

  • Prof. Martin Boeree
• 61 min
  6. Non-tuberculous mycobacterial pulmonary disease (NTM-PD)

  • Prof. Jakko van Ingen
• 51 min
  7. The making of an influenza pandemic

  • Prof. Jonathan Van-Tam
• 51 min
  8. Responding to pandemic influenza

  • Prof. Jonathan Van-Tam
  • Dr. Chloe Sellwood
• 38 min
  9. Controlling pandemic flu

  • Prof. John Oxford
• 30 min
  10. The future of influenza vaccines

  • Dr. Marc P. Girard
• 29 min
  11. Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide

  • Dr. Marietjie Venter
  • Mrs. Orienka Hellferscee
• 34 min
  12. RSV vaccine development

  • Prof. Ruth Karron
• 32 min
  13. Respiratory mycoplasmas

  • Prof. Stephen Gillespie
• 52 min
  14. Infection in the cystic fibrosis lung

  • Dr. Stuart Elborn
• 34 min
  15. The role of infection at COPD exacerbations

  • Prof. Wisia Wedzicha
• 58 min
  16. An overview of non-cystic fibrosis bronchiectasis

  • Dr. Maeve P. Smith
• 27 min
  17. Legionella: epidemiology and human infection, environment and diagnosis

  • Dr. Diane Lindsay
• 24 min
  18. Pathogen discovery in the respiratory tract

  • Dr. H. Rogier van Doorn
• 38 min
  19. Aspergillosis infections and the lung

  • Prof. Rosemary Barnes
• 23 min
  20. Parasitic lung infections: protozoa, cestodes & trematodes

  • Dr. Vannan Kandi Vijayan
• 16 min
  21. Parasitic lung infections: nematodes

  • Dr. Vannan Kandi Vijayan
• 37 min
  22. Improving respiratory diagnostics (viruses)

  • Prof. David Murdoch

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Talk overview
3. Pneumococcal serotype
4. Capsule biosynthesis genes
5. Capsule antigenicity
6. Global serotype distribution of IPD in children (1)
7. Global serotype distribution of IPD in children (2)
8. Serotype distribution: age, syndrome or body fluid
9. Regional serotype distribution
10. Regional prevalence of serotypes
11. Regional serotype distribution by age
12. Serotype-specific disease and mortality
13. Serotype associated mortality
14. Serotype-specific incidence by region
15. Serotype-specific mortality by region
16. Epidemiology – pre-vaccine
17. Pneumococcal vaccines
18. Epidemiology – post-vaccine
19. IPD and HIV-positive epidemiology
20. How serotypes differ between carriage and IPD
21. Detailed nasopharyngeal ecology
22. Evolution during carriage
23. Geographic distribution of QS pherotypes
24. Multiple pherotypes co-colonizing the nasopharynx
25. Conclusions

Topics Covered

• Pneumococcal serotype
• Capsule biosynthesis genes and antigenicity
• Global serotype distribution of IPD in children
• Serotype distribution: age, syndrome or body fluid
• Regional serotype distribution & prevalence
• Serotype-specific disease incidence & mortality by region
• Epidemiology (pre- and post-vaccine)
• Pneumococcal vaccines
• IPD and HIV-positive epidemiology
• How serotypes differ between carriage and IPD
• Detailed nasopharyngeal ecology
• Evolution during carriage
• Geographic distribution of QS pherotypes
• Multiple pherotypes co-colonizing the nasopharynx

Links

Series:

• Respiratory Infection

Categories:

• Immunology
• Microbiology

Therapeutic Areas:

• Infectious Diseases
• Respiratory Diseases

Talk Citation

Publication History

• Published on July 11, 2013

Financial Disclosures

• Dr. Bambos Charalambous has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.